Published in Acta Cytol on August 29, 2005
Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis (2009) 1.35
Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer. Int J Cancer (2008) 1.21
Characterization of Molecular Markers Indicative of Cervical Cancer Progression. Proteomics Clin Appl (2009) 0.91
Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women. Infect Agent Cancer (2007) 0.88
Optical technologies and molecular imaging for cervical neoplasia: a program project update. Gend Med (2011) 0.85
Early impact and performance characteristics of an established anal dysplasia screening program: program evaluation considerations. Open AIDS J (2007) 0.84
Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM. Mod Pathol (2015) 0.80
Anal squamous cell carcinoma in the HIV-positive patient. Clin Colon Rectal Surg (2009) 0.80
Physician attitudes toward dissemination of optical spectroscopy devices for cervical cancer control: an industrial-academic collaborative study. Gend Med (2012) 0.76
Cost-effectiveness analysis of anal cancer screening in women with cervical neoplasia in British Columbia, Canada. BMC Health Serv Res (2016) 0.75
A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet (2006) 8.61
A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet (2004) 7.68
FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet (2000) 5.33
Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 4.76
Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85. Br Med J (Clin Res Ed) (1988) 4.60
Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res (2003) 4.22
Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 3.25
Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res (2006) 2.73
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res (2002) 2.71
Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 2.47
FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet (1999) 2.36
Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy. Am J Hematol (2014) 2.26
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res (2006) 2.24
High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH. Int J Cancer (2006) 2.16
Reflectance spectroscopy for in vivo detection of cervical precancer. J Biomed Opt (2002) 2.10
A stepwise framework for the normalization of array CGH data. BMC Bioinformatics (2005) 2.08
SeeGH--a software tool for visualization of whole genome array comparative genomic hybridization data. BMC Bioinformatics (2004) 2.04
Light scattering from cervical cells throughout neoplastic progression: influence of nuclear morphology, DNA content, and chromatin texture. J Biomed Opt (2003) 1.96
Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells. PLoS One (2009) 1.94
Plasmon resonance coupling of metal nanoparticles for molecular imaging of carcinogenesis in vivo. J Biomed Opt (2007) 1.90
Near real-time confocal microscopy of amelanotic tissue: detection of dysplasia in ex vivo cervical tissue. Acad Radiol (2002) 1.84
In vivo fiber-optic confocal reflectance microscope with an injection-molded plastic miniature objective lens. Appl Opt (2005) 1.83
EZH2 promotes E2F-driven SCLC tumorigenesis through modulation of apoptosis and cell-cycle regulation. J Thorac Oncol (2013) 1.72
Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol (2003) 1.72
Microanatomical and biochemical origins of normal and precancerous cervical autofluorescence using laser-scanning fluorescence confocal microscopy. Photochem Photobiol (2003) 1.69
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res (2008) 1.68
Invasive cancer of the cervix in British Columbia: a review of the demography and screening histories of 437 cases seen from 1985-1988. Obstet Gynecol (1992) 1.66
Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities. Blood (2013) 1.64
Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res (2002) 1.61
Quantitative histopathological analysis of cervical intra-epithelial neoplasia sections: methodological issues. Cell Oncol (2004) 1.58
Combined reflectance and fluorescence spectroscopy for in vivo detection of cervical pre-cancer. J Biomed Opt (2005) 1.56
New hope for an oral cancer solution: together we can make a difference. J Can Dent Assoc (2008) 1.55
Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 1.54
Contrast agents for confocal microscopy: how simple chemicals affect confocal images of normal and cancer cells in suspension. J Biomed Opt (2002) 1.53
Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy. J Clin Oncol (1992) 1.51
Effect of active smoking on the human bronchial epithelium transcriptome. BMC Genomics (2007) 1.50
In vivo optical coherence tomography imaging of preinvasive bronchial lesions. Clin Cancer Res (2008) 1.50
A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. J Natl Cancer Inst (2002) 1.50
FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet (1999) 1.49
Objective assessment of aesthetic outcomes of breast cancer treatment: measuring ptosis from clinical photographs. Comput Biol Med (2006) 1.47
Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV. Gynecol Oncol (2005) 1.47
Analytical model to describe fluorescence spectra of normal and preneoplastic epithelial tissue: comparison with Monte Carlo simulations and clinical measurements. J Biomed Opt (2004) 1.46
Optical spectroscopy for detection of neoplasia. Curr Opin Chem Biol (2002) 1.45
Carcinoma of the corpus uteri. J Epidemiol Biostat (2001) 1.42
Optimal excitation wavelengths for discrimination of cervical neoplasia. IEEE Trans Biomed Eng (2002) 1.42
Communicating colposcopy results: what do patients and providers discuss? J Low Genit Tract Dis (2008) 1.42
Epigenomics: mapping the methylome. Cell Cycle (2006) 1.42
Influence of fluorescence on screening decisions for oral mucosal lesions in community dental practices. J Oral Pathol Med (2013) 1.41
Lymphangioma circumscriptum of the vulva: a review of the literature. Obstet Gynecol (2003) 1.38
Carcinoma of the ovary. Int J Gynaecol Obstet (2003) 1.36
Sources of scattering in cervical tissue: determination of the scattering coefficient by confocal microscopy. Appl Opt (2005) 1.35
High-resolution array CGH increases heterogeneity tolerance in the analysis of clinical samples. Genomics (2005) 1.35
Fluorescence and reflectance device variability throughout the progression of a phase II clinical trial to detect and screen for cervical neoplasia using a fiber optic probe. J Biomed Opt (2007) 1.33
Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo. Cancer Gene Ther (2004) 1.32
Cervical intraepithelial neoplasia in British Columbia: a comprehensive program for detection, diagnosis, and treatment. Gynecol Oncol (1981) 1.31
Carcinoma of the corpus uteri. Int J Gynaecol Obstet (2003) 1.30
Model-based analysis of clinical fluorescence spectroscopy for in vivo detection of cervical intraepithelial dysplasia. J Biomed Opt (2006) 1.26
A phase I study of myo-inositol for lung cancer chemoprevention. Cancer Epidemiol Biomarkers Prev (2006) 1.25
Colposcopic accuracy in the diagnosis of microinvasive and occult invasive carcinoma of the cervix. Obstet Gynecol (1985) 1.25
Gestational trophoblastic neoplasia, FIGO 2000 staging and classification. Int J Gynaecol Obstet (2003) 1.23
Real-time reflectance confocal microscopy: comparison of two-dimensional images and three-dimensional image stacks for detection of cervical precancer. J Biomed Opt (2007) 1.23
Fiber-optic confocal reflectance microscope with miniature objective for in vivo imaging of human tissues. IEEE Trans Biomed Eng (2002) 1.23
Natural history of bronchial preinvasive lesions. Cancer Metastasis Rev (2010) 1.21
Fiber optic confocal reflectance microscopy: a new real-time technique to view nuclear morphology in cervical squamous epithelium in vivo. Opt Express (2003) 1.21
Kappa statistics to measure interrater and intrarater agreement for 1790 cervical biopsy specimens among twelve pathologists: qualitative histopathologic analysis and methodologic issues. Gynecol Oncol (2005) 1.19
Spatially resolved reflectance spectroscopy for diagnosis of cervical precancer: Monte Carlo modeling and comparison to clinical measurements. J Biomed Opt (2007) 1.19
Prevention of ovarian cancer: intraepithelial neoplasia. Clin Cancer Res (2003) 1.16
Predictors of breast and cervical screening in Vietnamese women in Harris County, Houston, Texas. Cancer Nurs (2005) 1.15
Light scattering from normal and dysplastic cervical cells at different epithelial depths: finite-difference time-domain modeling with a perfectly matched layer boundary condition. J Biomed Opt (2003) 1.15
Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines. Int J Cancer (2007) 1.14
MD-SeeGH: a platform for integrative analysis of multi-dimensional genomic data. BMC Bioinformatics (2008) 1.13
Effect of probe pressure on cervical fluorescence spectroscopy measurements. J Biomed Opt (2004) 1.13
Optical imaging of the cervix. Cancer (2003) 1.12
Chromosome 5p aberrations are early events in lung cancer: implication of glial cell line-derived neurotrophic factor in disease progression. Oncogene (2005) 1.10
Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions. Cancer Res (2008) 1.10
Carcinoma of the ovary. J Epidemiol Biostat (2001) 1.09
Evolving a strategic approach to cervical cancer control in Africa. Gynecol Oncol (2005) 1.09
Gain of a region on 7p22.3, containing MAD1L1, is the most frequent event in small-cell lung cancer cell lines. Genes Chromosomes Cancer (2006) 1.07
SIGMA: a system for integrative genomic microarray analysis of cancer genomes. BMC Genomics (2006) 1.07
Timed efficiency of interpretation of digital and film-screen screening mammograms. AJR Am J Roentgenol (2009) 1.05
Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions. Oncogene (2002) 1.05
Distress after an abnormal Pap smear result: scale development and psychometric validation. Prev Med (2004) 1.04
Exploratory analysis of quantitative histopathology of cervical intraepithelial neoplasia: objectivity, reproducibility, malignancy-associated changes, and human papillomavirus. Cytometry A (2004) 1.04
Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer. Clin Cancer Res (2006) 1.04
Results of a survey on digital screening mammography: prevalence, efficiency, and use of ancillary diagnostic AIDS. J Am Coll Radiol (2008) 1.03
Relationship between collagen autofluorescence of the human cervix and menopausal status. Photochem Photobiol (2003) 1.03
Objective screening for cervical cancer in developing nations: lessons from Nigeria. Gynecol Oncol (2007) 1.02
Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 1.02
Diffuse reflectance patterns in cervical spectroscopy. Gynecol Oncol (2005) 1.01
A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics (2009) 1.01